Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2011-03-10 |
| Study Made Public: | 2012-02-14 |
Title
Evaluate the potential use of SIV Env in generating neutralizing antibodies against HIV-1
Description
CAVD 333 is an immunogenicity study evaluating the potential use of SIV Env in generating neutralizing antibodies against HIV-1.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.